8th German Pharm-Tox Summit

Analysis of sex-specific differences in spontaneously submitted and systematically collected reports of serious adverse drug reactions

Pharmacoepidemiology and drug safety	

Oral presentation

Pharmacogenomics and personalized medicine	

Establishing an overexpression system for studying genetic variability in green tea catechins inhibition of organic anion transporting polypeptide 1A2 (OATP1A2) in vitro

Ion channels and membrane transporters	

Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.

Session 1

Poster

The role of steroid hormone levels on the E2-mediated CYP2B6 regulation in breast cancer cells in vitro

Cancer pharmacology	

Nuclear receptors, enzymes and other targets		

Characterization of the EMPAR cohort – Health care claims data and CYP2D6 profiles

Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.

Session 2

Effect of aging on the pharmacokinetics of metformin, penicillin, sumatriptan, and metoprolol in rats

Pharmacokinetics and PK/PD modelling	

Drug transport/delivery and metabolism

CYP dependent drug interactions in polypharmacy: a personalized medicine approach 

Pharmacological education

Pharmacogenetics in uncoupling susceptibility of CYP2B6 mediated substrate oxidation

Drug transport, metabolism and pharmacogenomics 

Development of a fast multiplexed UHPLC-MS/MS method for the determination of substrates and metabolites of the Aachen Phenotyping Cocktail to assess individual cytochrome P450 metabolism

Patient risk profiles in polytherapy: Patient-reported safety outcome measures, potentially inadequate medication (PIM) and drug-drug-interactions in an elderly cohort, a longitudinal investigation

Short talks

Chair

Regulatory science - real world clinical pharmacological data analyses in personalized medicine

Symposien

Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant

Julia Stingl

Vorsitz

Speaker

Weitere Beteiligungen